Luteolin can effectively inhibit the proliferation of NSCLC A549 cells by inducing apoptosis and inhibiting proinflammatory cytokines (IL-1β, IL-6, IL-8, and TNF-α) and VEGF, thus inhibiting angiogenesis [64]. The gene discussed is IL6; the disease is non-small cell lung carcinoma.